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case-vignette study
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Alison Holmes1,2 and the Percept-R Study Group
Abstract
Background: Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding
the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients.
Methods: In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field
of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted,
among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-
assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms
(MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the
agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their
national, organisational and individual characteristics.
Results: Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual
(clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-
lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases.
Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk
associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the
individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying
from 0.00 (ICC: 0–0.25) to 0.51 (0.18–0.85). The overall agreement across countries was poor at 0.20 (0.07–0.33). IC
specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01)
and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists
working in hospitals with a high MDRO clinical burden had a decreased risk perception.
Conclusions: The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying
on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate
both the individual and collective risks, and might further negatively promote the MDRO spread. These finding
highlight the need to shape local and national control strategies according to risk perceptions and contextual factors.
Keywords: Europe, Infection prevention and control, Antimicrobial resistance, Risk perception, Carbapenemase-
producing Enterobacteriaceae, Meticillin-resistant Staphylococcus aureus, Carbapenemase-producing Pseudomonas
aeruginosa, Carbapenemase-producing Acinetobacter baumannii, Vancomycin-resistant Enterococci
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Introduction
The burden of antimicrobial resistance (AMR) is highly
heterogeneous across European countries [1]. The con-
trol of this phenomenon requires global and coordinated
actions to prevent the spread of multidrug-resistant
organisms (MDRO) [2]. Despite this urgent need, strat-
egies for dealing with a common issue seem to be highly
variable across neighbouring countries, regions and hos-
pitals [3, 4]. In the same epidemiological context, some
hospitals are implementing strong “search and isolate”
strategies to control some MDROs, whereas others ap-
pear to take a more flexible approach [5].
The organisational framework, the socio-cultural and
economic context seem to play a role in the differences
of strategic approach. In some countries, infection con-
trol governance is centralised with a unique national
recommendation, while others opt for a decentralised
organisation with local adaptations [6]. Strategies may
rely on variable organisations from coercive systems to
governance based, the latter relies on the willingness of
healthcare professionals to comply with best practices
[7]. Furthermore, personal determinants, such as know-
ledge, belief, attitude and behaviours are closely linked
to the cultural, local and organisational contexts in
which decisions are made [8, 9]. We wanted to investi-
gate if and how the perception of AMR by infection con-
trol (IC) specialists varies according to individual
determinants (experience, position), the type of organ-
isms, the local/national epidemiology, the organisational
culture, the socio-cultural, and the economic context.
Understanding the perceptions of IC specialists regard-
ing MDRO and their associated risk to patients is a
prerequisite for the coordinated implementation of in-
terventions to prevent the emergence and dissemination
of AMR in healthcare settings.
This case-vignette study aimed to assess the percep-
tion of the risk associated with MDRO by IC specialists
across Europe in various clinical contexts. We also
studied potential influencing factors at the national, or-
ganisational and individual levels.
Methods
Population and location of the study
This study involved IC specialists involved in the pre-
vention of AMR in hospitals from 15 European countries
(Austria, Finland, France, Greece, Germany, Hungary,
Ireland, Israel, Netherland, Portugal, Serbia, Spain,
Turkey, United Kingdom and Ukraine). The participants
were recruited through national IC experts and members
of the European Committee on Infection Control
(EUCIC) from each country. These investigators were
asked to recruit 16 IC specialists involved in AMR
control, all working in different hospitals, leading to an
expected number of 240 participants. Between March to
June 2017, 245 IC experts were invited to participate in
the study, and 149 agreed.
Study design and data
We developed 16 case-vignettes based on real MDRO
cases in hospitals, using a standard list of items. The
case-vignettes were previously piloted and tested within
the team of main investigators (GB, NTM, RA, ET, J-CL,
AH). Each participant scored five randomly-assigned
case-vignettes to allow assessments of the agreement
across participants. For each vignette, the participants
were questioned on their perception of the individual
and collective risk associated with MDRO clinical cases
according to a numerical 7-class Likert-type scale, ran-
ging from “No risk” (score 1) to “High risk” (score 7)
[10]. The individual risk was defined as the occurrence
of a negative outcome for the colonised or infected pa-
tient. The collective risk was defined as the probability
of MDRO acquisition for contact patients (i.e. by sharing
the nursing staff with colonized patients). A secure
online relational database was established for data col-
lection. Before starting, each participant provided the
following information: age, hospital category, and experi-
ence in the current position.
Development of case-vignettes and questionnaires
We selected common AMR clinical cases experienced in
hospitals across the participating countries. The follow-
ing information were presented in vignettes: the
epidemiological situation (sporadic vs epidemic), type of
MDRO (three Methicillin-resistant Staphylococcus aur-
eus (MRSA), four extended-spectrum beta-lactamase
producing Enterobacteriaceae (ESBL-PE), four carbape-
nemase producing Enterobacteriaceae (CPE), two
Carbapenemase-resistant Acinetobacter baumannii (CR-
Ab), two vancomycin-resistant Enterococci (VRE), one
Carbapenemase-resistant Pseudomonas aeruginosa (CR-
Pa)), colonisation/infection, the timeline, the setting
(type of ward, awareness of staff on IC measures, anti-
biotic use, workload, ward architecture and number of
beds), and patients characteristics (colonisation/infec-
tion, autonomy, continence, devices, antibiotic treat-
ments, repatriated). For each MDRO type, vignettes
presented a various panel of epidemiological situations
and patient’s characteristics in different settings. Cases
details were presented chronologically in English lan-
guage (Supplementary Figure S1 and Table S1).
Individual, organisational and national factors
Participants completed a questionnaire developed to
evaluate the AMR control strategy in their hospital. The
11 criteria selected for this form were informed by the
IPC core components [11], including questions on the
management (i.e. presence of IPC committee), resources,
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training programmes and AMR surveillance (Supple-
mentary Table S2).
The local hospital epidemiology was assessed by the
number of bacteraemia with the six selected MDROs ob-
served in 2015 categorised in 0, 1–10 and > 10 episodes.
Data on national epidemiology were extracted from the
European Centre for Diseases prevention and Control
(ECDC) surveillance atlas of Infectious diseases, provid-
ing the percentage of resistant isolates per species
(resistant strains out of all strains) among invasive infec-
tions in 2015, and the Center for Disease Dynamics,
Economics & Policy (CDDEP) resistance map 2016 for
Turkey, and Serbia (Supplementary Table S3).
Individual cognitive factors for compliance with AMR
control measures were assessed through a questionnaire
(six questions) based on the “health belief model” [10].
This questionnaire enabled assessment of the individual
decision and if levels of adherence with best practice is
influenced by perceived susceptibility, perceived
knowledge, intention to adhere (perceived practice),
attitudes toward IC, perceived behavioural norms, per-
ceived subjective norms, self-efficacy, and motivation
(Supplementary Table S4).
The perception of the organisation and work condi-
tions in hospitals were evaluated using four dimensions
described in previous models [12, 13]. These models
enabled assessment of teamwork (seven questions),
management (nine questions), well-being and work con-
ditions (seven questions), and stress and chaos in the
work environment (two questions) at the hospital level
(Supplementary Table S5). Items related to beliefs and
perception were coded on a seven-point Likert scale,
ranging from one “strongly disagree” to seven “strongly
agree” with the statement of the item.
The socio-cultural factors included the national
values for four dimensions of the Hofstede classifica-
tion [14]: uncertainty avoidance (society’s tolerance
for uncertainty and ambiguity), power distance (extent
to which the less powerful members of organizations
accept that power is distributed unequally), masculin-
ity (masculine cultures based on ego, assertiveness
and success; feminine on caring for the weak and
quality of life), and individualism (degree to which
people are integrated into groups). The socio-
economic factors included Gross domestic product
and the health expenditure per capita extracted from
the Organisation for Economic Co-operation and
Development (OECD) statistics 2013 [15] (Supple-
mentary Table S6).
Data analysis and statistics
Sample size calculation
We estimated the number of vignettes and participants
needed to assess agreement based on the precision of
the intraclass correlation coefficient (ICC) [16], with 16
vignettes each scored five times and an expected ICC of
about 0.60, half the exact 95% confidence interval
(95%CI). Each participant had to score five vignettes
leading to an objective of 16 participants per country
and 240 participants in total for the included 15 coun-
tries. Data were described as mean+/−SD, median (inter-
quartile range), or percentage.
Data management and statistical analysis
The perceptions assessed through the seven-point Likert
scale were dichotomised on one to five versus six and
seven. A high-risk perception was attributed for six and
seven versus low/neutral risk for the remaining five
quotations. In the same way, items of the individual
cognitive factors for compliance with AMR control mea-
sures, and the perception of the organisation and work
conditions in hospitals were considered positive for six
and seven (“agree and strongly agree”) versus negative
for the remaining five quotations.
The analysis of factors associated with the risk percep-
tion was performed at the individual level. An
aggregated score was calculated for each individual, or-
ganisational or national factor corresponding to the
mean of quotations for each domain (aggregation of 11
criteria for the local IPC organisation, six criteria for the
perception of individual IC compliance, seven criteria
for teamwork, nine criteria for perception of manage-
ment, seven criteria for stress and chaos, and two criteria
for well-being and work conditions). Aggregated scores
and values obtained for the individual, organisational or
national factors were then dichotomized in high and low
levels (<p75 or ≥ p75). The epidemiological indicators
were categorised locally in three classes (0, 1- ≤ 10 or >
10 bacteraemia per year) and nationally following the
seven ECDC classes of resistant isolates proportions.
Categorical variables were expressed as frequency
(percentage). The ICC with the 95% confidence intervals
(CI) were computed to evaluate agreements for the
individual and collective perception based on 1–7 Likert
scale scores. An ICC of zero indicates the level of agree-
ment produced by chance alone and an ICC of one
indicates perfect agreement. We defined poor agreement
as ICC values less than 0.4, good agreement as ICC
values of 0.4 to 0.7, and very good agreement as ICC
values greater than 0.7 [17].
The individual, organisational and national factors
were compared between the two groups of risk percep-
tion (low/neutral and high risk as defined above) using
the Chi2 or their corresponding non-parametric versions,
Fisher test, as appropriate. Analyses were performed
using STATA, Version 12 (Stata Corp LP, College
Station, TX).
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Ethics committee approval
Full ethical approval was obtained from the Health
Research Authority (IRAS project ID is 192,130) and the
Institutional Review Board (IRB 00006477) of HUPNVS,
Paris 7 University, APHP before data collection. The
completion of questionnaires inferred consent.
Results
Participants
A total of 149 IC specialists (62% out of 240 planned)
from 15 European countries scored 655 case-vignettes
(Table 1). Among them, 128 (86%) fully completed the
questionnaire, and the remaining 21 participants quoted
at least one case-vignette. The mean duration of practice
in IC was 13.6 years (Median: 13 (8–20, min-max: 1–32),
working in public general hospitals (n = 74, 50%), univer-
sity hospitals (n = 72, 48%) and private hospitals (n = 3,
2%). These hospitals comprised an average of 791 acute
care beds (Median: 641 beds) and 182 non-acute care
beds (Median: 49 beds).
Risk perception
Overall, a high individual risk (clinical outcome) was
perceived for 52% of the case-vignettes. This percentage
varied according to countries (from 38% among Hungar-
ian to 83% for Portuguese participants) and MDRO
(from 29% (51 out of 173) for ESBL-PE cases to 73%
(124/169) for CPE cases) (Table 2). Participants declared
being influenced by the clinical situation in 85% of the
655 cases-vignettes quoted, by the resistance pattern of
the organism in 81%, and by the type of organism
(species) in 59% of cases (Supplementary Table S7). Re-
garding CPE cases, answers were influenced more by the
resistance pattern (93%) than for other organisms. For
CR-Pa, the clinical situation (93%), the resistance pattern
(93%) and the type of organism (88%) were consistently,
and highly influential on risk perception.
The collective risk was considered high in 54% of
case-vignettes, ranging from 32% among German and
Ukrainian to 83% for Portuguese participants. The per-
ception of high collective risk ranged from 35% (61/173)
for ESBL-PE cases to 72% (122/169) of quotations for
CPE cases. The setting in which the clinical case was
presented was the main influencing factor for the col-
lective risk perception (82%) followed by clinical charac-
teristics (69%), the resistance pattern (60%) and the type
of organism (57%).
The risk associated with VRE cases was considered
higher for the collective impact than for individual out-
comes (63% vs 40%), whereas the individual risk was
quoted higher than the collective risk for CR-Pa (69% vs
50%) and MRSA (53% vs 43%). The highest perceived
collective and individual risks were associated with
outbreaks due to CR-Ab and CPE, respectively, both
occurring in ICU settings (data not shown).
For a same case-vignette, the agreement of respon-
dents regarding the individual risk was low with an ICC
of 0.20 (0.07–0.33). The interrater reliability of the col-
lective risk was also low with an ICC of 0.17 (0.05–0.28)
(Fig. 1). When looking at the agreement by country, the
ICC of individual risk scores varied from 0.00 (95%CI,
0.00–0.25) for Serbia to 0.51 for France (0.29–0.74) and
Israel (0.18–0.85). The ICC of collective risk scores var-
ied from 0.00 (ICC: 0–0.21) in Greece to 0.73 (0.25–1)
in the Netherlands.
Relationship between risk perception and national,
organisational and individual factors
A total of 128 IC specialists completed the question-
naires on the organisational and individual factors. In
2015, 58% of participants experienced > 10 ESBL-PE in
their hospital and 48% > 10 MRSA bacteraemia. Regard-
ing CPE and CR-Ab, 69% of participants identified less
than 10 bacteraemia in their hospital (Supplementary
Table S8). Finally, 42% of participants had not experi-
enced VRE bacteraemia in 2015.
In median, participant’s hospitals were complying
with 77% (IQR: 62–85%) of the 11 local IPC compo-
nents. This percentage varied from 58% among
Ukrainians to 88% for French hospitals. In median,
67% (IQR: 33–83%) of respondents declared comply-
ing with the six individual cognitive factors related to
AMR control measures. This percentage varied from
Table 1 Distribution of participants, case-vignettes quoted and
questionnaires completed in each of the 15 European countries
Countries Number of participants,
N (%)
Number of case-vignettes
quoted, N (%)
Austria 7 (5) 35 (5)
Finland 5 (3) 21 (3)
France 16 (11) 80 (12)
Germany 10 (7) 41 (6)
Greece 14 (9) 61 (9)
Hungary 10 (7) 42 (6)
Ireland 8 (5) 30 (5)
Israel 8 (5) 39 (6)
Netherlands 6 (4) 16 (2)
Portugal 7 (5) 18 (3)
Serbia 13 (9) 53 (8)
Spain 15 (10) 75 (11)
Turkey 10 (7) 50 (8)
UK 12 (8) 56 (9)
Ukraine 8 (5) 38 (6)
Total 149 (100) 655 (100)
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50% (French, Irish, Portuguese, Turkish, British) to
100% for Finish participants (Supplementary Table S2
and Table S4).
The teamwork dimension was positive for 63% of
IC specialists, 58% for the perception of management,
69% for well-being and work conditions and finally
53% for the dimension stress and chaos (Supplemen-
tary Table S5).
When looking at the relationships between the risk
perception and contextual factors, the perception of a
high individual and collective risk were both signifi-
cantly correlated with a low local prevalence of
MDRO bacteraemia (respectively p = 0.01 and 0.001)
and a low national rate of resistant isolates among
invasive infections (respectively p = 0.003 and < 0.001)
(Table 3). The individual risk perception tended to be
higher for IC specialists with less than five years of
experience in the specialty.
The risk perception tended to be lower among par-
ticipants working in hospitals with a high level of IPC
organisation, embedded in national cultures based on
masculinity, individualism, power distance, and in
countries with a high degree of gross domestic prod-
uct and health expenditure. On the other hand, a
high-risk perception was globally observed among
participants selecting compliance with AMR control
measures, and based in hospitals with a high level of
work conditions.
Table 2 Proportion among the 149 European IC specialists perceiving a high individual and collective risk to patients globally and
by type of multidrug-resistant organisms
Footnotes:
Individual risk corresponds to the risk of poor clinical outcomes for infected/colonised patients; collective risk corresponds to the risk for contact patients to
become colonised and the transmission to other patients. N represents the total number of case-vignettes scored
Colours relate to the percentage of participants selecting the item where red = 0% of selection, yellow = 50% and green = 100% of selection by participants
Abbreviations: IC Infection control, MRSA Methicillin resistant Staphylococcus aureus, ESBL-PE Extended spectrum betalactamase producing Enterobacteriaceae, CPE
Carbapenemase producing Enterobacteriaceae, KPC Klebsiella pneumoniae carbapenemase, CR-Ab Carbapenem-resistant Acinetaobacter baumannii, VRE Vancomycin
resistant Enterococci, CR-Pa Carbapenemase Resistant-Pseudomonas aeruginosa
Fig. 1 Overall assessment of agreement about risk perception within and across 15 European countries. Footnote: Individual risk corresponds to
the risk of poor clinical outcomes for infected/colonised patients; collective risk corresponds to the risk for contact patients to become colonised
and the transmission to other patients. N represents the total number of case-vignettes scored. The risk perception was scored on a 7-point Likert
scale and then categorized in low risk for scores 1 to 3, neutral for a score of 4 and high risk for scores 5 to 7. Poor agreement: ICC < 0.4, Good
agreement: ICC 0.4 to 0.7, Very good agreement: ICC > 0.7. Abbreviations: ICC, intraclass correlation; CI, confidence interval; UK, United Kingdom
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Table 3 Factors associated with the risk perception to infected/colonised cases of antimicrobial resistance
Population-based
variables
Individual risk Collective risk
Number of participants
with a Low/Neutral-risk
perceptiona
Number of participants
with a High-risk
perceptiona
Univariate
analysis
(p value)
Number of participants
with a Low/Neutral-risk
perceptiona
Number of
participants with a
High-risk perceptiona
Univariate
analysis
(p value)
Participants years of practice as an IPC specialist (n = 128)
< 5 3 (7) 13 (15) 0.10 5 (12) 11 (13) 1.00
≥ 5 48 (94) 64 (83) 38 (88) 874 (87)
Type of healthcare facility of participants (n = 128)
Private hospitals 1 (2) 1 (1) 0.86 0 (0) 2 (2) 0.34
Public general hospital 24 (47) 40 (52) 25 (58) 39 (46)
University hospital 26 (51) 36 (47) 18 (42) 44 (52)
Number of acute care beds (n = 128)
< 300 13 (25) 16 (21) 0.72 10 (23) 19 (22) 0.97
300–600 11 (22) 21 (27) 10 (23) 22 (26)
≥ 600 27 (53) 40 (52) 23 (54) 44 (52)
Epidemiology of MDROs the year prior the study
Local number of MDRO bacteremia in 2015a, (n = 461)
0 42 (19) 64 (26) 0.01 15 (13) 91 (26) 0.001
1-≤ 10 81 (37) 107 (44) 45 (38) 143 (41)
> 10 94 (43) 74 (30) 57 (49) 111 (32)
National invasive infections, Resistant isolate % (n = 495)
< 1% 33 (14) 60 (23) 0.003 10 (9) 83 (23) < 0.001
1-< 5% 24 (10) 38 (15) 7 (5) 55 (15)
5-< 10% 13 (6) 25 (10) 11 (9) 27 (7)
10-< 25% 59 (25) 41 (16) 39 (30) 61 (17)
25-< 50% 32 (14) 35 (13) 21 (16) 46 (13)
50-< 75% 14 (6) 6 (2) 5 (4) 15 (4)
≥ 75% 59 (25) 56 (21) 35 (27) 80 (22)
Local IPC organisation
Low level 27 (53) 49 (64) 0.22 22 (51) 54 (64) 0.18
High level 24 (47) 28 (36) 21 (49) 31 (36)
Individual cognitive factors for compliance with AMR control measures
Low level 34 (67) 46 (60) 0.42 27 (63) 53 (62) 0.96
High level 17 (33) 31 (40) 16 (37) 32 (38)
Perception of the organization and work conditions in participants hospital
Teamwork
Low level 43 (84) 56 (73) 0.12 34 (79) 65 (76) 0.74
High level 8 (16) 21 (27) 9 (21) 20 (24)
Perception of management
Low level 42 (82) 54 (70) 0.12 33 (77) 63 (74) 0.75
High level 9 (18) 23 (30) 10 (23) 22 (26)
Stress and chaos
Low level 41 (80) 60 (78) 0.74 37 (86) 64 (75) 0.16
High level 10 (20) 17 (22) 6 (14) 21 (25)
Well-being and work conditions
Low level 37 (73) 53 (69) 0.65 31 (72) 59 (69) 0.75
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Discussion
Agreement regarding the risk perception of AMR by IC
specialists varied greatly across countries, individuals
and MDRO. The risk was consistently perceived low for
ESBL-PE cases and high for CPE cases. IC specialists
working in an environment preserved from MDRO were
characterised by their high perception of the individual
and collective risk. Conversely, IC specialists frequently
confronted with MDRO cases had a reduced risk
perception, potentially due to habituation. Individual
positive beliefs on work conditions and compliance with
best practices were more prevalent among participants
with a high-risk perception.
Nationally, IC specialists perceived CPE and CR-Pa as
of higher individual importance, and VRE or CR-Ab as a
collective issue. CPE and CR-Pa infections are widely
recognised to be associated with poor clinical outcomes,
especially among ICU patients [18, 19]. On the other
hand, VRE and CR-Ab are known to have a strong po-
tential for spreading [20]. In 2015 in Europe, third
Table 3 Factors associated with the risk perception to infected/colonised cases of antimicrobial resistance (Continued)
Population-based
variables
Individual risk Collective risk
Number of participants
with a Low/Neutral-risk
perceptiona
Number of participants
with a High-risk
perceptiona
Univariate
analysis
(p value)
Number of participants
with a Low/Neutral-risk
perceptiona
Number of
participants with a
High-risk perceptiona
Univariate
analysis
(p value)
High level 14 (27) 24 (31) 12 (28) 26 (31)
National socio-cultural factors
Power Distance
Low level 36 (71) 59 (77) 0.44 28 (65) 67 (79) 0.09
High level 15 (29) 18 (23) 15 (35) 18 (21)
Uncertainty Avoidance
Low level 41 (80) 55 (71) 0.25 32 (74) 64 (75) 0.91
High level 10 (20) 22 (29) 11 (26) 21 (25)
Individualism
Low level 33 (65) 57 (74) 0.26 28 (65) 62 (73) 0.36
High level 18 (35) 20 (26) 15 (35) 23 (27)
Masculinity
Low level 34 (67) 54 (70) 0.68 24 (60) 64 (75) 0.02
High level 17 (33) 23 (30) 19 (40) 21 (25)
Socio-economic factors
GDP per capita
Low level 41 (80) 63 (82) 0.84 33 (80) 71 (84) 0.35
High level 10 (20) 14 (18) 10 (20) 14 (16)
Health expenditure per capita
Low level 27 (53) 50 (65) 0.17 18 (42) 59 (69) 0.003
High level 24 (47) 27 (35) 25 (58) 26 (31)
Footnotes:
Individual risk corresponds to the risk of poor clinical outcomes for infected/colonised patients; collective risk corresponds to the risk for contact patients to
become colonised and the transmission to other patients
aLow/Neutral-risk perception: Mean Scores = 1–5; High-risk perception: Mean Scores = 6–7
Power distance index (PDI): The power distance index is defined as “the extent to which the less powerful members of organizations and institutions accept and
expect that power is distributed unequally”. A higher degree of the Index indicates that hierarchy is clearly established and executed in society, without doubt or
reason. A lower degree of the Index signifies that people question authority and attempt to distribute power
Uncertainty avoidance (UAI): The uncertainty avoidance index is defined as “a society’s tolerance for ambiguity”, in which people embrace or avert an event of
something unexpected, unknown, or away from the status quo. Societies that score a high degree in this index opt for stiff codes of behaviour, guidelines, laws,
and generally rely on absolute truth, or the belief that one lone truth dictates everything and people know what it is. A lower degree in this index shows more
acceptance of differing thoughts or ideas
Individualism vs. collectivism (IDV): This index explores the “degree to which people in a society are integrated into groups”. Individualistic societies have loose
ties that often only relate an individual to his/her immediate family. They emphasize the “I” versus the “we”. Its counterpart, collectivism, describes a society in
which tightly-integrated relationships tie extended families and others into in-groups. These in-groups are laced with undoubted loyalty and support each other
when a conflict arises with another in-group
Masculinity vs. femininity (MAS): In this dimension, masculinity is defined as “a preference in society for achievement, heroism, assertiveness and material rewards
for success”. In feminine societies, they share modest and caring views equally with men. In more masculine societies, women are somewhat assertive and
competitive, but notably less than men. In other words, they still recognize a gap between male and female values
Abbreviations: MDRO Multi-drug resistant organisms, IPC Infection prevention and control
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generation cephalosporin-resistant Enterobacteriaceae
represented the largest part of the burden caused by
antibiotic-resistant bacteria [1]. However, carbapenemase-
resistant K. pneumoniae showed the most significant posi-
tive trend in attributable deaths between 2007 and 2015.
The results on risk perception found for ESBL-PE in the
present study are not in line with this estimated burden. A
jump of public health attention from MRSA in the 2000s
to CPE in the 2010s, due to the rapid evolution of AMR
among Enterobacteriaceae, may have led to a rapid shift of
attentiveness explaining this result. In a context of rising
resistance levels, we may assume that resources are
devoted to the control of the MDRO considered the most
risky. According to our results, efforts may focus on the
control of CPE and CR-Pa mainly due to their resistance
pattern.
The local and national epidemiology of MDRO inva-
sive infections were the main factors associated with a
high-risk perception. The high level of risk perception
by IC specialists may come from an external pressure
formalised by a strong policy and commitment for the
control of MDRO. In this context, hospitals are enforced
to strictly implement control measures, leading to a low
AMR burden. Conversely, IC specialists working in hos-
pitals with a low incidence of MDRO may perceive each
emerging situation as a risk to patients. In reaction, they
would probably apply strict measures following national
recommendations if available. In hospitals with a high
AMR burden, the experience accumulated on MDRO,
and resources necessary for their control, may both alle-
viate the risk perception. In endemic situations, as for
ESBL-PE in many European countries, controlling the
spread of MDRO appears complex and requiring large
resources. In this case, hospitals and IC specialists may
not strictly apply guidelines, and operate in downgraded
mode softening the strategy. IC specialists frequently
managing MDRO outbreaks may get into a routine, with
a lighter vision of the risk.
IC specialists’ perceiving high risks were also those
with a consistent low (but non-significant) level of local
IPC organisation, national socio-cultural (based on fem-
ininity, collectivism and a low power distance), and/or
socio-economic factors. This same group selected com-
pliance with AMR control measures, and thought their
hospital to have a fair to good level of work conditions.
In this context, the level of risk perception may rely on
the lack of IPC infrastructure and resources, in organisa-
tions without clear leadership. Defining clear priorities
and engaging key stakeholders on the strategy for the
control of MDRO at the organisational level constitute
the first perspectives of improvement. In diametrically
opposed contexts, of low-level perception of risks,
actions should focus on raising individual IPC specialist
capability to comply with control measures, and
emphasising the horizontal approach of AMR prevention
with more collective decision-making, integrated and
team-based initiatives.
Several limitations need to be acknowledged. First, the
vignettes were scored for the risk perception and the IC
strategy by each participant in isolation which is contra
to most working practices. MDRO situations are often
complex, typically requiring discussion and collegial de-
cision making to adapt the strategy to the current
context (clinical, setting, and resources). Second, the vi-
gnettes were scored via an online database. The vignettes
were built from real cases, but the perception and deci-
sion making may be different than in the reality. More-
over, despite definitions provided for each criteria, the
variability of answers may be explained by the variability
of reading and understanding of case-vignettes presented
in English language. Third, in some countries we did not
reach the 16 expected IC specialists for participation. Fi-
nally, participants in each country were solicited by
national leaders in the field of AMR surveillance and
prevention. This recruitment method potentially induced
selection bias with a majority of participants working in
universities or large hospitals. However, IC specialists
working in these centres presumably have the most
experience with MDRO. According to these, we may
expect getting reliable answers on the risk perception,
reinforcing the theoretical role of individual and context-
ual determinants.
Conclusion
The risk perception regarding similar MDRO cases varied
across IC specialists and countries, relying on contextual
factors, including the epidemiology. A shared perception
of the risks represents an important prerequisite to the
harmonization of actions. For IC specialists with low risk
perception, the prominence of accountability and em-
powerment in the management of AMR seem to be key
elements of AMR control strategies.
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